{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Researchers say the milk is brimming with potential therapeutic agents, for babies and also possibly adults.", "headline": {"main": "Breast Milk Becomes a Commodity, With Mothers Caught Up in Debate", "print_headline": "Worries Vie With Hopes as Breast Milk Becomes Big Business"}, "abstract": "Breast milk is among latest frontiers of biotechnology industry, thereby becoming an industrial commodity; researchers say they hope to synthesize and distill variety of potential therapeutics from breast milk for treatment of varied diseases; skeptics of fledgling industry have expressed concerns, particularly about how it will impact nonprofit milk banks.", "print_page": "1", "word_count": "1418", "_id": "550c42517988100e8ac09f62", "snippet": "Researchers say the milk is brimming with potential therapeutic agents, for babies and also possibly adults.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/03/21/business/breast-milk-products-commercialization.html", "multimedia": [{"subtype": "wide", "url": "images/2015/03/21/business/21milk4-web/21milk4-web-thumbWide-v2.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/03/21/business/21milk4-web/21milk4-web-thumbWide-v2.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/03/21/business/21milk4-web/21milk4-web-articleLarge-v2.jpg", "height": 436, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/03/21/business/21milk4-web/21milk4-web-articleLarge-v2.jpg", "xlargeheight": "436"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/03/21/business/21milk4-web/21milk4-web-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/03/21/business/21milk4-web/21milk4-web-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Breastfeeding", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Biotechnology and Bioengineering", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Medolac Laboratories", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Prolacta Bioscience Inc", "is_major": "N", "rank": "5", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2015-03-21T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The drug, developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials.", "headline": {"main": "Biogen Reports Its Alzheimer\u2019s Drug Sharply Slowed Cognitive Decline", "print_headline": "Alzheimer\u2019s Drug Shows Promise in a Trial"}, "abstract": "Biogen Idec presents results of small Phase 1 trial of experimental Alzheimer's disease drug aducanumab in Nice, France, which suggest drug can sharply slow decline in mental function in patients; results, if replicated in larger studies, will revive hope for pharmaceutical approach to therapy that has long been elusive.", "print_page": "1", "word_count": "999", "_id": "550be9bc7988100e8ac09e49", "snippet": "The drug, developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/03/21/business/alzheimers-drug-trial-shows-cognitive-decline-sharply-slowed.html", "multimedia": [{"subtype": "wide", "url": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-articleLarge.jpg", "height": 453, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-articleLarge.jpg", "xlargeheight": "453"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/03/21/business/21alzheimer-web/21alzheimer-web-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Alzheimer's Disease", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Biogen Idec Inc", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Clinical Trials", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Dementia", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Eli Lilly and Company", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Johnson & Johnson", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Pfizer Inc", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Roche Holding AG", "is_major": "N", "rank": "9", "name": "organizations"}, {"value": "Nice (France)", "is_major": "N", "rank": "10", "name": "glocations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2015-03-21T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "OpEd", "lead_paragraph": "We need a global warning and response system for infectious disease outbreaks.", "headline": {"seo": "Bill Gates: The Ebola Crisis Was Terrible. But Next Time Could Be Much Worse.", "main": "How to Fight the Next Epidemic", "kicker": "Op-Ed Contributor", "print_headline": "How to Fight the Next Epidemic", "content_kicker": "Op-Ed Contributor"}, "abstract": null, "print_page": null, "word_count": "1035", "_id": "55095f7679881027c592c74c", "snippet": "We need a global warning and response system for infectious disease outbreaks.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/03/18/opinion/bill-gates-the-ebola-crisis-was-terrible-but-next-time-could-be-much-worse.html", "multimedia": [{"subtype": "wide", "url": "images/2015/03/19/opinion/19gates/19gates-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/03/19/opinion/19gates/19gates-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/03/19/opinion/19gates/19gates-articleLarge.jpg", "height": 558, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/03/19/opinion/19gates/19gates-articleLarge.jpg", "xlargeheight": "558"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/03/19/opinion/19gates/19gates-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/03/19/opinion/19gates/19gates-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Epidemics", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Viruses", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Bill", "lastname": "GATES"}], "original": "By BILL GATES"}, "document_type": "article", "pub_date": "2015-03-18T11:30:00Z", "section_name": "Opinion"}, {"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Questioning the Value of Health Apps", "kicker": "Well", "print_headline": "Pictures, if Not Proof, of Health"}, "abstract": "More than 100,000 apps claim to help consumers track their conditions. That doesn\u2019t mean they are all accurate.", "print_page": null, "word_count": "1073", "_id": "55072f0c79881074af54e2dc", "snippet": "More than 100,000 apps claim to help consumers track their conditions. That doesn\u2019t mean they are all accurate.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2015/03/16/health-apps-provide-pictures-if-not-proof-of-health/", "multimedia": [{"subtype": "wide", "url": "images/2015/03/17/science/17APPS/17APPS-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/03/17/science/17APPS/17APPS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/03/17/science/17APPS/17APPS-articleLarge.jpg", "height": 1066, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/03/17/science/17APPS/17APPS-articleLarge.jpg", "xlargeheight": "1066"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/03/17/science/17APPS/17APPS-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/03/17/science/17APPS/17APPS-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Smartphones", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Mobile Applications", "is_major": "Y", "rank": "3", "name": "subject"}], "byline": {"person": [{"firstname": "Joshua", "middlename": "A.", "lastname": "KRISCH", "rank": 1, "role": "reported", "organization": ""}], "original": "By JOSHUA A. KRISCH"}, "document_type": "blogpost", "pub_date": "2015-03-16T15:27:35Z", "section_name": "Health"}], "meta": {"hits": 4, "offset": 0, "time": 77}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}